N. L. Millar, C. Donnell, I. B. Mcinnes, and E. Brint, Wounds that heal and wounds that don't?The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis, Semin. Cell Dev. Biol, vol.16, pp.41-50, 2016.

R. Ghali, R. Altara, W. E. Louch, A. Cataliotti, Z. Mallat et al., IL-33 (interleukin 33)/SST2 (soluble suppression of tumorigenicity 2) axis in hypertension and heart failure, Hypertension, vol.72, pp.818-828, 2018.

S. Sanada, D. Hakuno, L. J. Higgins, E. R. Schreiter, A. N. Mckenzie et al., IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system, J. Clin. Investig, vol.117, pp.1538-1549, 2007.

S. Demyanets, V. Konya, S. P. Kastl, C. Kaun, S. Rauscher et al., Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques, Arterioscler. Thromb. Vasc. Biol, 2011.

E. Martínez-martínez, M. Miana, R. Jurado-lópez, E. Rousseau, P. Rossignol et al., López-Andrés, N. A role for soluble ST2 in vascular remodeling associated with obesity in rats, PLoS ONE, issue.8, p.79176, 2013.

L. Matilla, J. Ibarrola, V. Arrieta, A. Garcia-peña, E. Martinez-martinez et al., Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: An in vitro and in vivo study in aortic stenosis, Clin. Sci, vol.133, pp.1537-1548, 2019.

A. Bayés-genís, J. Núñez, and J. Lupón, Soluble ST2 for Prognosis and Monitoring in Heart Failure: The New Gold Standard?, J. Am. Coll. Cardiol, vol.70, pp.2389-2392, 2017.

A. V. Shinde and N. G. Frangogiannis, Mechanisms of Fibroblast Activation in the Remodeling Myocardium, Curr. Pathobiol. Rep, vol.5, pp.139-148, 2017.

J. G. Travers, F. A. Kamal, J. Robbins, K. E. Yutzey, and B. C. Blaxall, Cardiac fibrosis: The fibroblast awakens, Circ. Res, vol.118, pp.1021-1040, 2016.

C. Bang, C. Antoniades, A. S. Antonopoulos, U. Eriksson, C. Franssen et al., Intercellular communication lessons in heart failure, Eur. J. Heart Fail, vol.17, pp.1091-1103, 2015.

V. Arrieta, E. Martinez-martinez, J. Ibarrola, V. Alvarez, R. Sádaba et al., López-Andrés, N. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis, Clin. Sci, vol.131, pp.935-949, 2017.

J. Ibarrola, E. Martínez-martínez, J. R. Sádaba, V. Arrieta, A. García-peña et al., Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model, Int. J. Mol. Sci, vol.18, p.1664, 2017.

C. Hampton, R. Rosa, B. Campbell, R. Kennan, L. Gichuru et al., Early echocardiographic predictors of outcomes in the mouse transverse aortic constriction heart failure model, J. Pharmacol. Toxicol. Methods, vol.84, pp.93-101, 2017.

A. Feldman, E. Weinberg, P. Ray, and B. Lorell, Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding, Circ. Res, vol.73, pp.184-192, 1993.

J. Ibarrola, V. Arrieta, R. Sádaba, E. Martinez-martinez, A. Garcia-peña et al., Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage?, Clin. Sci, vol.132, pp.1471-1485, 2018.

J. Ibarrola, R. Sádaba, A. Garcia-peña, V. Arrieta, E. Martinez-martinez et al., A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts, Int. J. Cardiol, vol.258, pp.217-223, 2018.

R. Altara, R. Ghali, Z. Mallat, A. Cataliotti, G. W. Booz et al., Conflicting vascular and metabolic impact of the IL-33/sST2 axis, Cardiovasc. Res, vol.114, pp.1578-1594, 2018.

R. Kakkar and R. T. Lee, The IL-33/ST2 pathway: Therapeutic target and novel biomarker, Nat. Rev. Drug Discov, vol.7, pp.827-840, 2008.

A. Nagata, N. Takezako, H. Tamemoto, H. Ohto-ozaki, S. Ohta et al., Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells, Cell Mol. Immunol, vol.9, pp.399-409, 2012.

D. L. Mann, Mechanisms and models in heart failure: A combinatorial approach, Circulation, vol.100, pp.999-1008, 1999.

A. Bayes-genis, M. De-antonio, J. Vila, J. Peñafiel, A. Galán et al., Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3, J. Am. Coll. Cardiol, vol.63, pp.158-166, 2014.

Y. Glinka, S. Stoilova, N. Mohammed, and G. J. Prud'homme, Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta, Carcinogenesis, vol.32, pp.613-621, 2011.

C. Pellet-many, P. Frankel, H. Jia, and I. Zachary, Neuropilins: Structure, function and role in disease, Biochem. J, vol.411, pp.211-226, 2008.

Z. Ding, W. Du, Z. Lei, Y. Zhang, J. Zhu et al., Neuropilin 1 modulates TGF-?1-induced epithelial-mesenchymal transition in non-small cell lung cancer, Int. J. Oncol, vol.2020, pp.531-543

S. Cao, U. Yaqoob, A. Das, U. Shergill, K. Jagavelu et al., Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF? signaling in hepatic stellate cells, J. Clin. Investig, vol.120, pp.2379-2394, 2010.

P. N. Matkar, K. K. Singh, D. Rudenko, Y. J. Kim, M. A. Kuliszewski et al., Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma, Oncotarget, vol.7, pp.69489-69506, 2016.

Z. G. Ma, Y. P. Yuan, H. M. Wu, X. Zhang, and Q. Z. Tang, Cardiac fibrosis: New insights into the pathogenesis, Int. J. Biol. Sci, vol.14, pp.1645-1657, 2018.

P. Kong, P. Christia, and N. G. Frangogiannis, The pathogenesis of cardiac fibrosis, Cell Mol. Life Sci, vol.71, pp.549-574, 2014.

S. Thakur, L. Li, and S. Gupta, NF-?B-mediated integrin-linked kinase regulation in angiotensin II-induced pro-fibrotic process in cardiac fibroblasts, Life Sci, vol.107, pp.68-75, 2014.

G. Valen, Z. Q. Yan, and G. K. Hansson, Nuclear factor kappa-B and the heart, J. Am. Coll. Cardiol, vol.38, pp.307-314, 2001.

N. Takezako, M. Hayakawa, H. Hayakawa, S. Aoki, K. Yanagisawa et al., ST2 suppresses IL-6 production via the inhibition of I?B degradation induced by the LPS signal in THP-1 cells, Biochem. Biophys. Res. Commun, vol.341, pp.425-432, 2006.